Abdallah, Nadine H. http://orcid.org/0000-0001-9195-1589
Lakshman, Arjun
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Cook, Joselle http://orcid.org/0000-0001-5335-9533
Binder, Moritz http://orcid.org/0000-0001-9014-9658
Kapoor, Prashant http://orcid.org/0000-0002-4342-364X
Dispenzieri, Angela http://orcid.org/0000-0001-8780-9512
Gertz, Morie A. http://orcid.org/0000-0002-3853-5196
Lacy, Martha Q.
Hayman, Suzanne R.
Buadi, Francis K. http://orcid.org/0000-0003-3214-0203
Dingli, David http://orcid.org/0000-0001-7477-3004
Lin, Yi http://orcid.org/0000-0002-1556-6416
Kourelis, Taxiarchis http://orcid.org/0000-0001-8573-9434
Warsame, Rahma
Bergsagel, Leif http://orcid.org/0000-0003-1523-7388
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Article History
Received: 23 September 2023
Revised: 28 December 2023
Accepted: 5 January 2024
First Online: 17 January 2024
Competing interests
: SVR reports grants from NIH, outside the submitted work. PK received research funding from Takeda Pharmaceuticals, Celgene, and Amgen. AD received research funding from Celgene, Millennium Pharmaceuticals, Pfizer, and Janssen and received a travel grant from Pfizer. MAG served as a consultant for Millennium Pharmaceuticals and received honoraria from Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Novartis, GlaxoSmithKline, Prothena, Ionis Pharmaceuticals, and Amgen. MQL received research funding from Celgene. SKK served as a consultant for Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Janssen, and Bristol-Myers Squibb and received research funding from Celgene, Millennium Pharmaceuticals, Novartis, Onyx Pharmaceuticals, AbbVie, Janssen, and Bristol-Myers Squibb. The remaining authors declare no competing interests.